Concepedia

Akriti Kharbanda

AK

Statistics

Publications

15

Citations

1.2K

H-Index

15

Active since

2011

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

University of Pennsylvania

Genus Oncology (United States)

UPMC Hillman Cancer Center

Akriti Kharbanda is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2011–2020

15

Publications

15

Inhibition of DHHC20-Mediated EGFR Palmitoylation Creates a Dependence on EGFR Signaling

Kristin B. Runkle, Akriti Kharbanda, Ewa Stypulkowski et al. · Molecular Cell · 2016 · 231 citations · Full text

, , +7

MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial–mesenchymal transition

Hasan Rajabi, M Alam, Hidekazu Takahashi et al. · Oncogene · 2013 · 119 citations

, , +16

Long-lived keratin 15+ esophageal progenitor cells contribute to homeostasis and regeneration

Véronique Giroux, Ashley Lento, Mirazul Islam et al. · Journal of Clinical Investigation · 2017 · 117 citations · Full text

, , +12

Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells

Deepak Raina, Yoshiaki Uchida, Akriti Kharbanda et al. · Oncogene · 2013 · 107 citations · Full text

, , +17

Blocking EGFR palmitoylation suppresses PI3K signaling and mutant KRAS lung tumorigenesis

Akriti Kharbanda, David M. Walter, A. Andrea Gudiel et al. · Science Signaling · 2020 · 94 citations · Full text

, , +16

1–5 of 15